Roes Alexander L, Patel Martin K
Utrecht University, Copernicus Institute, Department of Science Technology and Society (STS), Heidelberglaan 2, 3584 CS Utrecht, The Netherlands.
Risk Anal. 2007 Oct;27(5):1311-21. doi: 10.1111/j.1539-6924.2007.00959.x.
This article describes the development and application of a generic approach to the comparative assessment of risks related to the production of organic chemicals by petrochemical processes versus white biotechnology. White biotechnology, also referred to as industrial biotechnology, typically uses bio-based feedstocks instead of the fossil raw materials used in the petrochemical sector. The purpose of this study was to investigate whether the production of chemicals by means of white biotechnology has lower conventional risks than their production by petrochemical processes. Conventional risks are the risks of well-established processes, and not those related to genetically modified microorganisms and plants. Our approach combines classical risk assessment methods (largely based on toxicology), as developed by the life cycle assessment (LCA) community, with statistics on technological disasters, accidents, and work-related illnesses. Moreover, it covers the total process chain for both petrochemical and bio-based products from cradle to grave. The approach was applied to five products: the plastics polytrimethylene terephthalate (PTT), polyhydroxyalkanoates (PHA), polyethylene terephthalate (PET), polyethylene (PE), and ethanol. Our results show that the conventional risks related to the white biotechnology products studied are lower than those of the petrochemical products. However, considering the uncertainties with respect to the ranges of input data, the (incomplete) coverage of emissions by the environmental priority strategies (EPS) 2000 method, and the uncertainties of the assumptions made in this study (i.e., large to very large), the differences in results between bio-based and petrochemical products fall into the uncertainty range. Because of this, future research is necessary to decrease the uncertainties before we can conclude that the conventional risks of biotechnologically produced chemicals are lower than those of fossil-fuel-derived chemicals.
本文介绍了一种通用方法的开发与应用,该方法用于比较石化工艺与白色生物技术生产有机化学品相关风险。白色生物技术,也被称为工业生物技术,通常使用生物基原料而非石化行业所使用的化石原料。本研究的目的是调查通过白色生物技术生产化学品是否比通过石化工艺生产具有更低的传统风险。传统风险是成熟工艺的风险,而非与转基因微生物和植物相关的风险。我们的方法将生命周期评估(LCA)领域开发的经典风险评估方法(主要基于毒理学)与技术灾难、事故及与工作相关疾病的统计数据相结合。此外,它涵盖了石化产品和生物基产品从摇篮到坟墓的整个过程链。该方法应用于五种产品:塑料聚对苯二甲酸丙二醇酯(PTT)、聚羟基脂肪酸酯(PHA)、聚对苯二甲酸乙二酯(PET)、聚乙烯(PE)和乙醇。我们的结果表明,所研究的白色生物技术产品的传统风险低于石化产品。然而,考虑到输入数据范围的不确定性、环境优先策略(EPS)2000方法对排放的(不完整)覆盖以及本研究中所作假设的不确定性(即大到非常大),生物基产品和石化产品之间的结果差异落在不确定性范围内。因此,在我们能够得出生物技术生产的化学品的传统风险低于化石燃料衍生化学品的结论之前,有必要进行进一步研究以降低不确定性。